Skip to content
Screener

Baxter International BAX Healthcare Systems & Technologies — Other segment items

Other segment segments

Medical Products & Therapies
-$26M-23.8%
Pharmaceuticals
-$7M0.0%

Similar metrics at other companies

Consensus Cloud Solutions, Inc. logo
CCSIReportable Segment — Other segment items
$11.82M+3.6%
IR
IRIndustrial Technologies and Services — Other segment items
$400K-71.4%
IR
IRPrecision and Science Technologies — Other segment items
$100K
Korn Ferry logo
KFYRPO — Other segment items
$1.12M-27.2%
Korn Ferry logo
KFYEMEA — Other segment items
$234K+14.7%
Korn Ferry logo
KFYConsulting — Other segment items
$2.52M-36.7%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$14.13B+22.3%
Enterprise value$12.33B+22.1%
P/S1.3×+0.2×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:OtherExpenses.

The source filing: Baxter International’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:50 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028962
(in millions)Three Months Ended March 31, 2026 / Medical Products & TherapiesThree Months Ended March 31, 2026 / Healthcare Systems & TechnologiesThree Months Ended March 31, 2026 / PharmaceuticalsThree Months Ended March 31, 2025 / Medical Products & TherapiesThree Months Ended March 31, 2025 / Healthcare Systems & TechnologiesThree Months Ended March 31, 2025 / Pharmaceuticals
Net sales$1,285$705$621$1,262$704$581
Cost of sales781390458694356396
Selling, general and administrative expenses290209102286217103
Research and development expenses544922594526
Other segment items(26)(9)(7)(21)(7)(7)
Segment operating income$186$66$46$244$93$63

Item 1. Financial Statements (unaudited)

FAQ

What is Baxter International's healthcare systems & technologies — other segment items?
Baxter International (BAX) reported healthcare systems & technologies — other segment items of -$9M in Q1 2026.
How has Baxter International's healthcare systems & technologies — other segment items changed year-over-year?
Baxter International's healthcare systems & technologies — other segment items decreased by 28.6% year-over-year, from -$7M to -$9M.
What does healthcare systems & technologies — other segment items mean?
Includes non-recurring or miscellaneous income and expense items specific to the segment that do not fit into standard operating categories. This may include restructuring charges, legal settlements, or minor asset disposals.

Ask your AI about Baxter International's healthcare systems & technologies — other segment items.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude